Graph showing significantly increased neurite lengths after 48 h treatment with oxyntomodulin (*p = 0.04), exendin-4 (*p = 0.01) and GLP-1 (*p = 0.04) using Students unpaired t-test (E)
PlexusDx also accepts HSA and FSA payments, further reducing your out-of-pocket cost
Gastrointestinal side effects such as nausea, vomiting, and constipation are most common during dose escalation
Effectiveness of nutritional ingredients on upper gastrointestinal conditions and symptoms: A narrative review
doi: 10.1016/0014-2999(78)90251-0, 37
We believe the results of this study provide further validation of the rapid impact the Allurion Program can have in patients with obesity and other co-morbidities, says Shantanu Gaur, MD, founder and CEO of Allurion, in a release